Chen et al. used Lats-IN-1 to inhibit Hippo pathway and found that overexpression of DNAJB4 suppressed the adverse biological characteristics of breast cancer through modulation of the Hippo pathway and the tumor’s immune suppression context. The gene discussed is DNAJB4; the disease is breast cancer.